ÂÜÀòÂÒÂ×

Paul B. has extensive work experience in the pharmaceutical industry, spanning over two decades. Paul currently serves as the Vice President of Quality Assurance at BlueRock Therapeutics, where they lead the development and implementation of the Quality System and oversees GMP operations staff and facility. Paul has also established and led a team of 23 quality professionals to support drug manufacturing processes, from raw materials to finished products. In addition, they have experience in supplier qualification programs, quality oversight, and review of quality events.

Prior to their role at BlueRock Therapeutics, Paul held various positions at Checkmate Pharmaceuticals, where they served as the Vice President of Quality and Senior Director of Quality. In these roles, they provided executive leadership to ensure GxP compliance and developed quality strategies and systems across GCP/GLP/GMP areas. Paul also designed and deployed a comprehensive quality suite for all GxP systems.

Before their time at Checkmate Pharmaceuticals, Paul worked at Gilead Sciences as a Research Scientist and Senior Manager of Analytical Outsourcing. Paul led a team responsible for external analytical operations, cross-functional initiatives, and budget management. Additionally, they served as a QC Manager at Biogen Idec, where they established and managed external QC testing vendors and built strategic relationships with key providers.

Paul began their career at FIRA International Ltd as a Materials Technologist and later held positions at Capsugel (Division of Pfizer), Pharmalucence, Pacira Pharmaceuticals, and GSK. Notably, at Capsugel, they served as a Principal Scientist and Head of Quality Control/Quality Assurance, overseeing compliance with cGMP and managing quality documentation and analytical data generation.

Throughout their career, Paul has demonstrated expertise in quality management, supplier qualification, analytical method development and validation, and regulatory compliance. Paul'swork experience showcases their strong leadership skills and ability to navigate complex quality systems in the pharmaceutical industry.

Paul B. has a Master of Science (MS) degree in Chemistry with Chemical Biology from Northeastern University. Paul also holds a Bachelor of Science (BSc) degree in Chemistry from Anglia Ruskin University. Additionally, they have a Higher National Certificate (HNC) in Chemistry from the University of Hertfordshire.